Journal of Diabetes & Metabolism

ISSN - 2155-6156

Citations Report

Journal of Diabetes & Metabolism : Citations & Metrics Report

Articles published in Journal of Diabetes & Metabolism have been cited by esteemed scholars and scientists all around the world. Journal of Diabetes & Metabolism has got h-index 43, which means every article in Journal of Diabetes & Metabolism has got 43 average citations.

Following are the list of articles that have cited the articles published in Journal of Diabetes & Metabolism.

  2024 2023 2022 2021 2020 2019

Total published articles

123 107 59 61 45 23

Research, Review articles and Editorials

44 54 37 40 21 22

Research communications, Review communications, Editorial communications, Case reports and Commentary

5 1 2 5 3 0

Conference proceedings

6 16 5 7 0 45

Citations received as per Google Scholar, other indexing platforms and portals

632 946 1156 1199 1039 1106
Journal total citations count 10648
Journal impact factor 12.50
Journal 5 years impact factor 18.23
Journal cite score 23.62
Journal h-index 43
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal citescore
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
Important Citations

Aronow WS (2015) Blood pressure target goals from guidelines of 2002–2014. Future cardiology 11: 247-250.

Aronow WS (2014) What Should the Systolic Blood Pressure Treatment Goal Be in Patients Aged 60 Years and Older with Hypertension?. Current Geriatrics Reports 3: 299-305.

Malyszko J, Banach M (2014) Pre-CKD-do we need another hero?. Current vascular pharmacology 12: 642-648.

Kjeldsen SE, Schumacher H, Neldam S, Guthrie RM (2013) Telmisartan/hydrochlorothiazide combination therapy for the treatment of hypertension: a pooled analysis in older and younger patients. The Journal of Clinical Hypertension 15: 380-388.

Malyszko J, Banach M (2013) Prediabetes, prehypertension-do we need pre-CKD. Curr Vasc Pharmacol.

Aronow WS (2014) Commentary on recent guidelines for treating hypertension. Arch Med Sci 10: 1069-1072.

Aronow WS (2013) Hypertension-related stroke prevention in the elderly. Current hypertension reports 15: 582-589.

Zaporowska-Stachowiak I, Hoffmann K, Bryl W, Minczykowski A (2014) Aliskiren-an alternative to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in the therapy of arterial hypertension. Arch Med Sci 10: 830-836.

Aronow WS (2015) Lipid-lowering therapy in older persons. Arch Med Sci 11: 43-56.

Carpenter MA, John A, Weir MR, Smith SR, Hunsicker L, et al. (2014) BP, cardiovascular disease, and death in the folic acid for vascular outcome reduction in transplantation trial. Journal of the American Society of Nephrology 25: 1554-1562.

Filippatos TD, Rizos EC, Gazi IF, Lagos K, Agouridis D, et al. (2013) Differences in metabolic parameters and cardiovascular risk between American Diabetes Association and World Health Organization definition of impaired fasting glucose in European Caucasian subjects: a cross-sectional study. Arch Med Sci 9: 788-795.

Franczyk-Skóra B, Gluba A, Olszewski R, Banach M, Rysz J (2014) Heart function disturbances in chronic kidney disease-echocardiographic indices. Arch Med Sci 10: 1109-1116.

Khanagavi J, Gupta T, Aronow WS, Shah T, Garg J, et al. (2014) Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes. Arch Med Sci 10: 251-257.

Banach M, Serban C, Aronow WS, Rysz J, Dragan S, et al. (2014) Lipid, blood pressure and kidney update 2013. International urology and nephrology 46: 947-961.

Banach M, Aronow WS (2012) Blood pressure j-curve: current concepts. Current hypertension reports 14: 556-566.

Ye F, Zeng Y, Sha J, Jones T, Kuhne K, et al. (2016) High Glucose Induces Reactivation of Latent Kaposi's Sarcoma-Associated Herpesvirus. Journal of Virology 90: 9654-9663.

Sheline CT, Shi C, Takata T, Zhu J, Zhang W, et al. (2012) Dietary zinc reduction, pyruvate supplementation, or zinc transporter 5 knockout attenuates β-cell death in nonobese diabetic mice, islets, and insulinoma cells. The Journal of nutrition 142: 2119-2127.

Rahimi M, Niromand E, Ajami E, Egbalian A, Barati M, et al. (2016) BELIFS ON INSULIN INJECTION NON-ADHERENCE AMONG TYPE 2 DIABETIC PATIENTS: ASSESSMENTBASED ON HEALTH BELIEF MODEL. Iranian Journal of Diabetes and Metabolism 15: 110-119.

Gulsen G, Olgun N (2016) Identifying experiences of individuals with Type 2 diabetes during acceptance and adaptation of insulin therapy. International Diabetes Nursing 9: 1-8.

Visram H (2013) Patient barriers to insulin use in multi-ethnic populations. Canadian journal of diabetes 37: 202-204.

Top